| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.63B | 40.56B | 40.56B | 42.40B | 40.03B | 41.57B |
| Gross Profit | 7.36B | 9.72B | 9.73B | 10.10B | 8.48B | 8.58B |
| EBITDA | 3.06B | 5.45B | 4.87B | 5.85B | 4.91B | 5.01B |
| Net Income | 973.00M | 2.44B | 1.79B | 2.54B | 1.30B | 1.43B |
Balance Sheet | ||||||
| Total Assets | 49.56B | 56.90B | 54.55B | 48.59B | 46.91B | 51.34B |
| Cash, Cash Equivalents and Short-Term Investments | 9.98B | 8.21B | 6.48B | 11.68B | 12.24B | 12.90B |
| Total Debt | 3.96B | 7.58B | 5.01B | 9.00M | 13.00M | 23.00M |
| Total Liabilities | 11.79B | 17.71B | 16.76B | 12.30B | 12.29B | 12.54B |
| Stockholders Equity | 37.77B | 39.19B | 37.79B | 36.29B | 34.62B | 38.80B |
Cash Flow | ||||||
| Free Cash Flow | 3.00B | 46.00M | -7.48B | 1.37B | 5.69B | 1.56B |
| Operating Cash Flow | 3.62B | 1.48B | 2.14B | 2.33B | 6.43B | 1.92B |
| Investing Cash Flow | 1.08B | -288.00M | -9.99B | -2.04B | -1.42B | -11.59B |
| Financing Cash Flow | -1.98B | 1.54B | 3.95B | -849.00M | -5.64B | -971.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥71.77B | 18.88 | 17.96% | 1.83% | 13.23% | 16.07% | |
78 Outperform | ¥32.96B | 8.18 | ― | 2.93% | 2.11% | 5.55% | |
76 Outperform | ¥156.92B | 14.81 | ― | 2.30% | 13.82% | 37.07% | |
74 Outperform | ¥290.60B | 28.54 | ― | 0.22% | 25.00% | 62.07% | |
65 Neutral | ¥31.81B | 6.28 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥41.67B | 74.72 | ― | 2.77% | -2.93% | -30.16% |